NOVO-AMPICILLIN SUS 125MG/5ML DIN 00021121
Health Canada record
| Active ingredient(s) | AMPICILLIN 125 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01CA01 AMPICILLIN |
| Original market date | 31-Dec-1971 |
| Current status date | 10-Aug-2005 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing AMPICILLIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00603279 | APO AMPI CAPSULES 250MG | APOTEX INC | Capsule | AMPICILLIN 250 MG | Cancelled Post Market |
| 00603295 | APO AMPI CAPSULES 500MG | APOTEX INC | Capsule | AMPICILLIN 500 MG | Cancelled Post Market |
| 00603260 | APO AMPI LIQ 125MG/5ML | APOTEX INC | Liquid | AMPICILLIN 125 MG | Cancelled Post Market |
| 00603287 | APO AMPI LIQ 250MG/5ML | APOTEX INC | Suspension | AMPICILLIN 250 MG | Cancelled Post Market |
| 00785873 | JAA AMP TAB 125MG | JAAPHARM CANADA INC. | Tablet | AMPICILLIN 125 MG | Cancelled Post Market |
| 00231207 | NOVO-AMPICILLIN PWS 500MG/5ML | NOVOPHARM LIMITED | Powder For Solution | AMPICILLIN 500 MG | Cancelled Post Market |
| 00021148 | NOVO-AMPICILLIN SUS 250MG/5ML | NOVOPHARM LIMITED | Powder For Solution | AMPICILLIN 250 MG | Cancelled Post Market |
| 00717657 | NU-AMPI CAPSULES 250MG | NU-PHARM INC | Capsule | AMPICILLIN 250 MG | Cancelled Post Market |
| 00717673 | NU-AMPI CAPSULES 500MG | NU-PHARM INC | Capsule | AMPICILLIN 500 MG | Cancelled Post Market |
| 00717495 | NU-AMPI SUS 125MG/5ML | NU-PHARM INC | Suspension | AMPICILLIN 125 MG | Cancelled Post Market |
| 00717649 | NU-AMPI SUSPENSION 250MG/5ML | NU-PHARM INC | Suspension | AMPICILLIN 250 MG | Cancelled Post Market |
| 00002003 | PENBRITIN CAP 250MG | AYERST LABORATORIES | Capsule | AMPICILLIN 250 MG | Cancelled Post Market |
| 00002011 | PENBRITIN CAP 500MG | AYERST LABORATORIES | Capsule | AMPICILLIN 500 MG | Cancelled Post Market |
| 00002429 | PENBRITIN PWS 250MG/5ML | AYERST LABORATORIES | Powder For Solution | AMPICILLIN 250 MG | Cancelled Post Market |
| 00251690 | PRO AMPI 250 CAP 250MG | PRO DOC LIMITEE | Capsule | AMPICILLIN 250 MG | Cancelled Post Market |
| 00628360 | PRO AMPI 500 CAP 500MG | PRO DOC LIMITEE | Capsule | AMPICILLIN 500 MG | Cancelled Post Market |
| 00284009 | PRO BIOSAN KIT | ICN CANADA LTD. | Tablet; Capsule | AMPICILLIN 500 MG; PROBENECID 500 MG | Cancelled Post Market |
| 02030527 | TARO-AMPICILLIN CAP 250MG | TARO PHARMACEUTICALS INC | Capsule | AMPICILLIN 250 MG | Cancelled Post Market |
| 02030535 | TARO-AMPICILLIN CAP 500MG | TARO PHARMACEUTICALS INC | Capsule | AMPICILLIN 500 MG | Cancelled Post Market |
International API supply for AMPICILLIN
1 valid EDQM Certificates of Suitability from 1 holders. 25 active FDA Drug Master Files.
Request a quote for NOVO-AMPICILLIN SUS 125MG/5ML